ES2068158B1 - PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF. - Google Patents

PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF.

Info

Publication number
ES2068158B1
ES2068158B1 ES9301932A ES9301932A ES2068158B1 ES 2068158 B1 ES2068158 B1 ES 2068158B1 ES 9301932 A ES9301932 A ES 9301932A ES 9301932 A ES9301932 A ES 9301932A ES 2068158 B1 ES2068158 B1 ES 2068158B1
Authority
ES
Spain
Prior art keywords
compositions
derivatives
applications
pharmaceutical compositions
fitic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES9301932A
Other languages
Spanish (es)
Other versions
ES2068158A1 (en
Inventor
Freixedas Feliciano Grases
Isern Juan Gabriel March
Bauza Antonia Costa
Almirall Rafael Maria Prieto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universitat de les Illes Balears
Original Assignee
Universitat de les Illes Balears
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitat de les Illes Balears filed Critical Universitat de les Illes Balears
Priority to ES9301932A priority Critical patent/ES2068158B1/en
Publication of ES2068158A1 publication Critical patent/ES2068158A1/en
Application granted granted Critical
Publication of ES2068158B1 publication Critical patent/ES2068158B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

COMPOSICIONES FARMACEUTICAS DE ACIDO FITICO O SUS DERIVADOS Y APLICACIONES DE LAS MISMAS. LAS COMPOSICIONES COMPRENDEN: 50-100 MG DE ACIDO FITICO Y/O SUS FITATOS FARMACEUTICAMENTE ACEPTABLES; 1500-3000 U.I. DE PROVITAMINA A Y/O VITAMINA A; 2-5 MG DE SALES DE ZN(II) Y EXCIPIENTE EN CANTIDAD SUFICIENTE POR DOSIS UNITARIA. ESTAS COMPOSICIONES TIENEN APLICACION COMO INHIBIDORES DE LA FORMACION DE CRISTALES DE OXALATO CALCICO EN EL RIÑON Y PROTECTORES DEL UROEPITELIO Y, POR TANTO, PARA EL TRATAMIENTO DE LOS ESTADOS PATOLOGICOS O PREPATOLOGICOS DERIVADOS DE LA LITIASIS RENAL OXALOCALCICA IDIOPATICA. ASIMISMO DICHAS COMPOSICIONES SE UTILIZAN EN LA FABRICACION DE MEDICAMENTOS Y COMPLEMENTOS DIETETICOS COADYUVANTES DEL REFERIDO TRATAMIENTO.PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF. THE COMPOSITIONS INCLUDE: 50-100 MG OF FITIC ACID AND / OR ITS PHARMACEUTICALLY ACCEPTABLE PHYTATES; 1500-3000 U.I. FROM PROVITAMINE A AND / OR VITAMIN A; 2-5 MG OF ZN (II) SALTS AND EXCIPIENT IN SUFFICIENT AMOUNT PER UNIT DOSE. THESE COMPOSITIONS HAVE APPLICATION AS INHIBITORS OF THE FORMATION OF CRYSTALS OF CALCIUM OXALATE IN THE KIDNEY AND PROTECTORS OF UROEPITHELIUM AND, THEREFORE, FOR THE TREATMENT OF THE PATHOLOGICAL OR PREPATHOLOGICAL STATES DERIVED FROM OXALOCAL RENAL LITIASIS. ALSO, SUCH COMPOSITIONS ARE USED IN THE MANUFACTURE OF MEDICINES AND DIETARY COMPLEMENTS COADJUVANTS OF THE REFERRED TREATMENT.

ES9301932A 1993-09-08 1993-09-08 PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF. Expired - Fee Related ES2068158B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9301932A ES2068158B1 (en) 1993-09-08 1993-09-08 PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9301932A ES2068158B1 (en) 1993-09-08 1993-09-08 PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF.

Publications (2)

Publication Number Publication Date
ES2068158A1 ES2068158A1 (en) 1995-04-01
ES2068158B1 true ES2068158B1 (en) 1995-11-16

Family

ID=8283025

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9301932A Expired - Fee Related ES2068158B1 (en) 1993-09-08 1993-09-08 PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF.

Country Status (1)

Country Link
ES (1) ES2068158B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2555166A1 (en) * 2014-06-25 2015-12-29 Universitat De Les Illes Balears Compositions of phytic acid, magnesium and polyphenols and their application for the prevention of oxalkalcic renal lithiasis (Machine-translation by Google Translate, not legally binding)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1190140B (en) * 1963-07-30 1965-04-01 Vismara Francesco Spa Process for the production of ACTH preparations
DE3327840C1 (en) * 1983-08-02 1984-09-20 Blendax Werke Schneider Co Skin care products
US5211956A (en) * 1988-05-19 1993-05-18 Sanwa Kagaku Kenkyusho Co., Ltd. Pharmaceutical compositions containing phytic acid or its salts
ES2007238A6 (en) * 1988-06-17 1989-06-01 Univ Illes Balears Zinc phytate prepn.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2555166A1 (en) * 2014-06-25 2015-12-29 Universitat De Les Illes Balears Compositions of phytic acid, magnesium and polyphenols and their application for the prevention of oxalkalcic renal lithiasis (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
ES2068158A1 (en) 1995-04-01

Similar Documents

Publication Publication Date Title
BR9506028A (en) Oral dosage form of multiple unit dosage in tablet processes for preparing it for the inhibition of gastric acid secretion in mammals and in man and for the treatment of inflammatory gastrointestinal diseases in mammals and in man and transverse pressure ampoule packaging
GB2303629B (en) Hydroxamic acids and their use as metalloproteinase inhibitors
AR020001A1 (en) ACTIVATING COMPOUNDS OF hPPARGAMMA AND hPPARALFA, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD FOR THE TREATMENT AND / OR PREVENTION OF A DISEASE MEDIATED BY THE SAME, AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
BR9807824A (en) Derivatives of n-hydroxy-beta-sulfonyl-propionamide and its use as matrix metalloproteinase inhibitors
AR035533A1 (en) USE OF AT LEAST AN INHIBITOR OF THE ABSORPTION OF THE STEROLS OR THEIR SALTS, SOLVATOS, PHARMACEUTICALLY ACCEPTABLE DRUGS OR MIXTURES OF THE SAME FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF SITOSTEROLEMIA, COMPOSITIONS OF THE PHARMACEUTICAL USE
AR006678A1 (en) DERIVATIVES OF TRICYCLIC MACROLIDES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM, USE OF THEM TO PREPARE MEDICINES AND PROCEDURE FOR THEIR PREPARATION
ES530242A0 (en) A PROCEDURE FOR PREPARING SALTS FROM AN IMIDAZOLE DERIVATIVE
AR039978A1 (en) TREATMENT AND PREVENTION OF OSTEOPOROSIS
IL107157A0 (en) Immunopotentiatory agents and pharmaceutical compositions comprising them
FI962735A (en) Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as a preventive for colon cancer and chemotherapeutic agent
AR019853A1 (en) DERIVED FROM THE 3-ARIL-2-HYDROXIPROPIONIC ACID, PROCESS AND INTERMEDIARY FOR THEIR PREPARATION, PHARMACEUTICAL FORMULATIONS, USE OF SUCH COMPOUND IN THE PREPARATION OF A MEDICINAL PRODUCT, METHOD FOR THE PROPHYLAXIS AND / OR TREATMENT OF CLINIC ASSOCIATED RESISTANCES AND FORMULATION
MY128014A (en) Thiol and thiocarbonyl derivatives which are useful as carboxypeptidase u inhibitors
IT1265101B1 (en) DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID
ES2095870T3 (en) DERIVATIVES OF HIDANTOINA OR IMIDAZOLIDINOTRIONA FOR THE TREATMENT OR PREVENTION OF RENAL INSUFFICIENCY.
ES2068158B1 (en) PHARMACEUTICAL COMPOSITIONS OF FITIC ACID OR ITS DERIVATIVES AND APPLICATIONS THEREOF.
KR101588949B1 (en) Anti-cancer supplement agent comprising flunarizine for glioma
ES2094638T3 (en) N-ACILPIRROLIDINAS AND MEDICINES FOR THE TREATMENT OR PREVENTION OF DISORDERS RELATED TO CHOLECYSTOCININ AND GASTRINE.
ES2043943T3 (en) PROCEDURE FOR THE PREPARATION OF COMPOUNDS WITH CENTRAL ANALGESIC ACTIVITY.
ES2065855B1 (en) PROCEDURE FOR THE PREPARATION OF NEW DEOXIAZAPHOSPHOLIPIDIC DERIVATIVES WITH INHIBITING ACTION OF THE PHOSFOLIPASE A2, NEW DERIVATIVES DEOXIAZAPHOSPHOLIPIDICES OBTAINED AND USE OF THEM.
AR008095A1 (en) SUBSTITUTED INDANILIDINEACETILGUANIDINES, PROCEDURE FOR THE PREPARATION, USE IN THE PREPARATION OF MEDICINES OR DIAGNOSTIC AGENTS, AS A CONTAINING MEDICATION
ES2058025B1 (en) APPLICATION OF THE FITIC ACID AND / OR ITS PHYTATES IN THE PATHOLOGICAL AND PREPATHOLOGICAL STATES DERIVED FROM THE IDIOPATIC RENAL LITHIASIS OF THE KIDNEY.
BR0016329A (en) Bis-indolylmaleimides substituted to inhibit cell proliferation
ATE441653T1 (en) PHOSPHORUS CONTAINING COMPOUNDS WITH ANTITHROMBITIC EFFECT
AR004402A1 (en) CYCLIC SULPHONES, PROCEDURE TO PREPARE THEM, CONTAINING PHARMACEUTICAL PREPARATIONS AND USE OF THE SAME TO FIGHT DISEASES.
AR023344A1 (en) 4-ARYLOXYINDOLES, A PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM AND THE USE OF THE SAME FOR THE PREPARATION OF MEDICINES

Legal Events

Date Code Title Description
FD2A Announcement of lapse in spain

Effective date: 20141120